Education

FDA Approves Moderna’s mRNA RSV Vaccine — With No Input From Independent Advisers

The FDA said it bypassed input from the agency’s independent advisers because it didn’t see any “concerns or controversial issues.” Moderna is running at least 11 clinical trials for its new mRNA RSV drug on other demographic groups, including young children, adolescents and healthy adults. by Brenda Baletti, Ph.D. This article was originally published by The

FDA Approves Moderna’s mRNA RSV Vaccine — With No Input From Independent Advisers Read More »

Powerful Public Comment to National Academies re: Adverse Vaccine Events

On March 30, 2023 the National Academies of of Sciences, Engineering, and Medicine heard an hour and a half of powerful public comment about vaccine adverse events. The closed-door meeting was minimally described as: “This is a virtual committee meeting. Committee members will meet in closed deliberative sessions to discuss the report. There will be

Powerful Public Comment to National Academies re: Adverse Vaccine Events Read More »